Testing effectiveness (Phase 2)Active Not RecruitingNCT05013450What this trial is testingDupilumab_Metastatic NSCLCWho this might be right forMetastatic Non-small Cell Lung Cancer Thomas Marron 33
Early research (Phase 1)Active Not RecruitingNCT06125197What this trial is testingOncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung CancerWho this might be right forLung Cancer TILT Biotherapeutics Ltd. 22
Early research (Phase 1)Study completedNCT00327288What this trial is testingSafety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsWho this might be right forNon-small Cell Lung CancerBreast CancerProstate Cancer AmpliMed Corporation 34
Testing effectiveness (Phase 2)Study completedNCT00405951What this trial is testingSafety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung CancerWho this might be right forLung Cancer Gemin X 47
Testing effectiveness (Phase 2)Ended earlyNCT00126451What this trial is testingA Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)Who this might be right forBreast CancerColorectal CancerNon-small-cell Lung Carcinoma Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Looking for participantsNCT06901817What this trial is testingThe Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal MetastasesWho this might be right forLeptomeningeal Metastasis Shanghai Cancer Hospital, China 97
Early research (Phase 1)Study completedNCT00066768What this trial is testingSuramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerWho this might be right forRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00921310What this trial is testingTemsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Washington University School of Medicine 12
Testing effectiveness (Phase 2)UnknownNCT01803503What this trial is testingDocetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid TumorsWho this might be right forSolid TumorsBreast CancerNon-small Cell Lung Cancer+2 more National University Hospital, Singapore 80
Testing effectiveness (Phase 2)Looking for participantsNCT07070518What this trial is testingStudy of GV20-0251 in Participants With Solid Tumor MalignanciesWho this might be right forSolid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+6 more GV20 Therapeutics 350
Testing effectiveness (Phase 2)Looking for participantsNCT06495125What this trial is testingDefactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung CancerWho this might be right forAdvanced Lung AdenocarcinomaRefractory Lung AdenocarcinomaStage III Lung Cancer AJCC v8+1 more Emory University 50
Testing effectiveness (Phase 2)Ended earlyNCT00251589What this trial is testingA Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)Who this might be right forCarcinoma, Non-Small-Cell Lung Merck Sharp & Dohme LLC 23
Testing effectiveness (Phase 2)UnknownNCT00014547What this trial is testingBBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous TreatmentWho this might be right forLung Cancer Theradex
Testing effectiveness (Phase 2)Looking for participantsNCT04691817What this trial is testingTocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based TherapyWho this might be right forLung Cancer, Nonsmall Cell Abramson Cancer Center at Penn Medicine 28
Early research (Phase 1)Looking for participantsNCT05227326What this trial is testingAOH1996 for the Treatment of Refractory Solid TumorsWho this might be right forRefractory Malignant Solid NeoplasmOsteosarcomaLeiomyosarcomas+4 more City of Hope Medical Center 92
Not applicableStudy completedNCT02623257What this trial is testingEGFR Mutations on ctDNA in Patients With Advanced NSCLCWho this might be right forNon-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic First People's Hospital of Hangzhou 1,055
Early research (Phase 1)Ended earlyNCT02313012What this trial is testingSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsWho this might be right forNeoplasm Metastasis Celgene 19
Early research (Phase 1)Ended earlyNCT05274451What this trial is testingInvestigate LYL797 in Adults With Solid TumorsWho this might be right forTriple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more Lyell Immunopharma, Inc. 57
Early research (Phase 1)Study completedNCT01069575What this trial is testingSafety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Shiga University 18
Early research (Phase 1)Study completedNCT01391143What this trial is testingSafety Study of MGA271 in Refractory CancerWho this might be right forProstate CancerMelanomaRenal Cell Carcinoma+4 more MacroGenics 179